je.st
news
Tag: achieved
Higher Rating Achieved On RF Inductors For Military
2015-10-13 07:09:57| rfglobalnet Home Page
Gowanda Electronics, a designer and manufacturer of precision electronic components for radio frequency and power applications, announced achievement of failure rate Level R on two more of its MIL-PRF-39010 RF Inductor Series – ER15M and ER18M – adding to the company’s series already approved to Level R – ER10M and ER17S.
Tags: rating
higher
military
achieved
'Climate deal cannot be achieved passing burden of action'
2015-10-09 01:57:00| Climate Ark Climate Change & Global Warming Newsfeed
Economic Times: Expressing disappointment with the low level of ambition displayed by developed nations to tackle climate change, India has said a lasting deal at the climate summit this year will not be achieved by passing the burden of action onto the shoulders of developing countries. Deputy Permanent Representative to the UN Bhagwant Bishnoi said India's "very ambitious" Intended Nationally Determined Contribution to tackle climate change in the post- 2020 period is in line with "our firm belief that while...
World's First LTE 3CA Validation Achieved By Anritsu RF Conformance Test System
2015-09-22 07:19:13| rfglobalnet News Articles
Anritsu Company announces that its ME7873LA LTE-Advanced RF Conformance Test System has obtained the world's first LTE 3CA PTCRB certification. By obtaining PTCRB certification for 3CA, the ME7873LA supports deployment of LTE 3CA downlink, expected to be available in North America by the end of the year.
Tags: system
test
achieved
worlds
World's First LTE 3CA Validation Achieved By Anritsu RF Conformance Test System
2015-09-22 07:19:13| wirelessdesignonline News Articles
Anritsu Company announces that its ME7873LA LTE-Advanced RF Conformance Test System has obtained the world's first LTE 3CA PTCRB certification. By obtaining PTCRB certification for 3CA, the ME7873LA supports deployment of LTE 3CA downlink, expected to be available in North America by the end of the year.
Tags: system
test
achieved
worlds
Mercks Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor, Achieved Similar A1C Reductions to JANUVIA (sitagliptin) in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
2015-09-16 16:16:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that omarigliptin, Mercks investigational once-weekly DPP-4 inhibitor in development for adults with type 2 diabetes, achieved its primary efficacy endpoint in a Phase 3 study. Omarigliptin was found to be non-inferior to Mercks once-daily DPP-4 inhibitor, JANUVIA (sitagliptin), at reducing patients A1C* levels from baseline, with similar A1C reductions achieved in both groups. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Michael Close, 310-617-1067Kristen Drake, 917-647-6223orInvestorsJustin Holko, 908-740-1879Teri Loxam, 908-740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: on
type
similar
controlled
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »